E, W., B, C., S, G., T, A., W, N., PC, G., . . . JD, G. (2026). Dual CDK2 and CDK4/6 inhibition suppresses Rb/E2F signaling and enhances anti-leukemic activity in acute myeloid leukemia. Haematologica. https://doi.org/10.3324/haematol.2026.300728
Chicago Style (17th ed.) CitationE, Weisberg, et al. "Dual CDK2 and CDK4/6 Inhibition Suppresses Rb/E2F Signaling and Enhances Anti-leukemic Activity in Acute Myeloid Leukemia." Haematologica 2026. https://doi.org/10.3324/haematol.2026.300728.
MLA (9th ed.) CitationE, Weisberg, et al. "Dual CDK2 and CDK4/6 Inhibition Suppresses Rb/E2F Signaling and Enhances Anti-leukemic Activity in Acute Myeloid Leukemia." Haematologica, 2026, https://doi.org/10.3324/haematol.2026.300728.
Warning: These citations may not always be 100% accurate.